Genome Medical will use the proceeds of its Series A-1 financing to expand its nationwide footprint, as well as to invest in its telegenomics platform.
The Martinos Center, Envision Genomics, and startup RowAnalytics are building an open precision medicine platform called Giro Health on IBM architecture.
At the Cleveland Clinic Medical Innovation Summit, experts discussed the promise and challenges of genomic and health data, and strategies for taming it.
By analyzing EMRs and genomic data, Mendel Health believes its AI platform can identify patients for ongoing trials and help clinicians select treatments.
Stat News reports that IBM's Watson for Oncology isn't yet living up to its promise.
The newly announced Microbiome Immunity Project seeks to discover links between autoimmune diseases and bacteria in and on the human body.
The collaboration will place T1D in the field of precision medicine, potentially allowing JDRF to identify factors that potentially lead to T1D.
New York Genome Center, Rockefeller University, and IBM researchers combined whole-genome sequencing with Watson to analyze a glioblastoma sample.
Through the alliance, Cornell has joined the Consortium for Sequencing the Food Supply Chain, an initiative launched by IBM and Mars in early 2015.
Baheal will be the primary channel partner in China for IBM's Watson for Genomics data analytics platform.
Cancer researcher Alan Rabson has died at 92, the New York Times reports.
As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.
The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.
In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.